There Is A Quest For Clarity Surrounding Karyopharm Therapeutics Inc (NASDAQ: KPTI) Volatility

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Karyopharm Therapeutics Inc is $121.24M. A total of 1.43 million shares were traded on the day, compared to an average of 1.25M shares.

In the most recent transaction, PAKIANATHAN DEEPIKA sold 341,040 shares of KPTI for 0.95 per share on Jun 04 ’24. After the transaction, the Director now owns 7,911 company shares. In a previous transaction on Jun 04 ’24, Paulson Richard A. sold 3,592 shares at 0.99 per share. KPTI shares that President and CEO owns now total 1,150,105.

Among the insiders who sold shares, Mason Michael disposed of 652 shares on Jun 04 ’24 at a per-share price of $0.99. This resulted in the EVP, CFO & Treasurer holding 398,104 shares of KPTI after the transaction. In another insider transaction, PAKIANATHAN DEEPIKA sold 360,744 shares at $1.00 per share on Jun 03 ’24. Company shares held by the Director now total 11,209.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, KPTI has a high of $2.47 and a low of $0.62.

As of this writing, KPTI has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.34. The company reported an EPS of -$0.29 in the last quarter

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. KPTI’s latest balance sheet shows that the firm has $228.62M in Cash & Short Term Investments as of fiscal 2021. There were $180.58M in debt and $73.72M in liabilities at the time. Its Book Value Per Share was -$1.45, while its Total Shareholder’s Equity was -$79.67M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KPTI is Buy with a score of 4.57.

Most Popular

Related Posts